pathtalk.org is a weblog about pathology and laboratory medicine.

Posts from category Molecular Pathology

Re: “Hemepath” post from 7/18/09

Sorry for the delay in following up with my case!  It was a good initial presentation of chronic myelogenous leukemia, chronic phase.
So, to start off with, the 5% “unclassified cells” were myeloid blasts without Auer rods.  In addition, the peripheral smear shows mostly granulocytes in varying stages of maturation.  The mature bands and neutrophils do [...]

Posted by
Keith Kaplan

Date
May 13, 2009
9:05 pm

Tagged

Category
Molecular Pathology

Response to comments on post about lawsuit involving Myriad Genetics

Yesterday I posted a short note with reference to a story involving an ACLU lawsuit against Myriad Genetics which has re-opened the discussion about patenting genes, that is human DNA.  The company of course went through this discussion to obtain the patent as others have and are no doubt prepared for this action to protect [...]

Updates on Molecular Cancer Pathology

www.oncopathology.blogspot.com
1) Molecular profiling may help determine patient’s response to cancer therapies, research suggests.
A pilot study of molecular profiling of tumors, helped to identify therapies that ultimately had an impact on the disease.The University of Texas MD Anderson Cancer Center and the Memorial Sloan-Kettering Cancer Center are “striving to profile individual tumors so that therapy [...]

Testing-testing: drug dosing based on SNPs?

Warfarin is one of the most commonly prescribed anticoagulants for prophylaxis and treatment of venous and arterial thromboembolic disorders or those at high risk for such disorders. Warfarin also has an FDA-issued “Black Box” warning for a high risk of fatal bleeding, most commonly from the gastrointestinal tract and in the brain. It acts [...]

Testing-testing: CGH me baby!!

Testing-testing: CGH me baby: I want to know how I measure up to the reference.
This is a very superficial post touching on an increasingly utilized testing methodology.
Comparative genomic hybridization (CGH) (also has been called “competitive”) is a method for scanning the entire genome for variations in DNA copy number which is not currently common in [...]

Testing-testing: Two SNPs for $200

The ASCP daily newsletter dated 10/12/07 had a short paragraph about home kit DNA diagnostics. Risk assessment for tailored treatment plans is a marketing strategy supporting the use of DIY (do-it-yourself) DNA swabs fishing for SNPs (single nucleotide polymorphisms) deemed as high risk in some common diseases such as atrial fibrillation. The current prevalence of [...]